Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GEMCITABINE vs GIANVI: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GEMCITABINE vs GIANVI: Safety Overview

Metric GEMCITABINE GIANVI
Total FAERS Reports 31,328 212
Deaths Reported 5,142 2
Death Rate 16.4% 0.9%
Hospitalizations 12,268 86
Average Patient Age 61.2 yrs 30.1 yrs
% Female Patients 48.4% N/A
FDA Approval Date Apr 11, 2016 N/A
Manufacturer Hikma Pharmaceuticals USA Inc. N/A
Route INTRAVENOUS N/A
Marketing Status Discontinued N/A